This video is part of our "Motley Fool Conversations" series, in which Million Dollar Portfolio advisor Charly Travers and Motley Fool Stock Advisor analyst Jason Moser discuss topics around the investing world.
Charly and Jason are bringing you 10 stocks that you can buy and hold for the long term in your IRA to maximize its tax advantages. Charly likes the pharmaceutical companies for their high dividend yields (currently 3% to 4% for most of the global names) and their defensive characteristics (people need to use drugs in all economic environments). Of the world's largest pharmaceuticals, Novartis earns the top grade because of its diversified product portfolio and leadership position in the development of biosimilars.
Every now and again, we come across a stock that has us so excited we can hardly contain our investing enthusiasm. We've uncovered one such pick with so much promise that we've dubbed it "The Motley Fool's Top Stock for 2012." We've created a special free report for investors to uncover this soon-to-be rock star. The report highlights a company that is revolutionizing commerce in Latin America, and you can get instant access to the name of this company by clicking here to download the report now.
At the time thisarticle was published Charly Travers and Jason Moser have no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson.Motley Fool newsletter services recommendJohnson & Johnson, Novartis, and Pfizer. Try any of our Foolish newsletter servicesfree for 30 days. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.